Top compounds associated with response to B9D2


Feature Type Standardized
Nominal ANOVA
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.096 0.004
mRNA 17-AAG CCLE pan-cancer AAC 0.14 0.004
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.093 0.004
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA fingolimod CTRPv2 pan-cancer AAC -0.11 0.005
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.005
mRNA linifanib GDSC1000 pan-cancer AAC 0.099 0.006
mRNA Topotecan CCLE pan-cancer AAC 0.12 0.006
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.006
mRNA BIBW2992 CTRPv2 pan-cancer AAC -0.11 0.006
Download CSV